peptuity
We track the signal in the peptide noise.
An independent, bilingual reference for the peptide space in the Gulf and MENA.
43
compounds assessed
15
bio-regulators
7
regulator-approved
2
languages, one desk
01
Start here
Emerging
BPC-157
Extensive animal healing data. Essentially no controlled human trials.
Well researched
GHK-Cu
The best human evidence of any ‘cosmetic’ peptide — but topically, not injected.
FDA approved
Semaglutide
GLP-1 agonist. Approved, trial-backed, and genuinely effective for weight and glycaemic control.
Well researched
Retatrutide
Triple agonist with the strongest phase 2 weight results yet — but not approved anywhere.
02
How we grade evidence
Five labels, applied consistently.
FDA approved
Approved by at least one major regulator for a defined indication.
Extensively studied
Multiple human randomised trials.
Well researched
Human data exists but is limited in size or scope.
Emerging
Mostly preclinical; early or pilot human work only.
Limited evidence
Little or no controlled human evidence.